Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence
Journal Title: Folia Neuropathologica - Year 2005, Vol 43, Issue 4
Abstract
Prion diseases or transmissible spongiform encephalopathies (TSEs) are rare neurodegenerative disorders that can be acquired either by direct transmission, inherited through dominant mutations in the prion protein gene or via an unknown sporadic cause. This latter group constitutes the vast majority of cases. Like many neurodegenerative diseases the hallmarks of oxidative damage can be readily detected throughout the brain of the affected individual. However, unlike most other neurodegenerative diseases, prion diseases are connected with a dramatic loss of antioxidant defence. As abnormal protein accumulates in the diseased brain there is both an increase of oxidative substances and a loss of the defences that keep them in check. In particular the normal cellular prion protein has been shown to be an antioxidant. Conversion of this protein to the protease resistant isoform is accompanied by a loss of this antioxidant activity. This change creates a paradox as the loss of activity is not accompanied by a loss of protein expression. It is likely that this prevents other cellular defences from responding sufficiently to protect neurons from the heightened oxidative burden. Recent experiments with transgenic mice have shown that when prion protein expression is switched off during the course of prion disease, cell death is dramatically halted and the mouse recovers from the disease. This result clearly illustrates that the continued expression of non-function prion protein is essential for disease progression. This implies that the presence of this abnormal protein during prion disease causes a failure of cellular antioxidant defence. This failed defence is the fundamental cause of the massive neurodegeneration that results in the fatal nature of TSEs. The role of oxidative stress in TSEs and other neurodegenerative disorders are discussed in this review.
Authors and Affiliations
David Brown
Keywords
Related Articles
- EP ID EP133846
- DOI -
- Views 74
- Downloads 0
Plaques and tangles and the pathogenesis of Alzheimer’s disease
Since the earliest descriptions, senile plaques (SP) and neurofibrillary tangles (NFT) have been regarded as the pathological hallmarks of Alzheimer’s disease (AD). Consequently, studies of the morphology, distribution...
Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion
Variant Creutzfeldt-Jakob disease (vCJD) was first identified in 1996 in the UK, and results from human exposure to the bovine spongiform encephalopathy (BSE) agent. vCJD has subsequently been identified in 10 additional...
Could lipid CH2/CH3 analysis by in vivo 1H MRS help in differentiation of tumor recurrence and post-radiation effects?
To inspect the potential diagnostic role of in vivo 1H MRS lipid methylene CH2 to methyl CH3 signal ratio in differentiation of recurrent brain tumor from radiation injury. Methods: Two patients – one with documented...
Frontotemporal dementia and parkinsonism linked to chromosome 17
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) is an autosomal dominant neurodegenerative disorder caused by mutations in the MAPT gene which encodes the microtubule-associated protein tau....
Changes of cytoskeletal proteins in ischaemic brain under cardiac arrest and reperfusion conditions
The aim of the study was to assess the level of calpain and its endogenous substrates – microtubule-associated protein 2 (MAP-2) and fodrin in the rodent model of global cerebral ischaemia caused by temporary cardiac arr...